Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

  • Showing results for a modified search because your search retrieved no results.
1.

Epigenetic regulation of oligodendrocyte identity.

Liu J, Casaccia P.

Trends Neurosci. 2010 Apr;33(4):193-201. doi: 10.1016/j.tins.2010.01.007. Epub 2010 Mar 12. Review.

2.

Oligodendrocyte-spinal cord explant co-culture: an in vitro model for the study of myelination.

Chen Z, Ma Z, Wang Y, Li Y, Lü H, Fu S, Hang Q, Lu PH.

Brain Res. 2010 Jan 14;1309:9-18. doi: 10.1016/j.brainres.2009.10.060. Epub 2009 Oct 30.

PMID:
19879858
3.

Lack of aspartoacylase activity disrupts survival and differentiation of neural progenitors and oligodendrocytes in a mouse model of Canavan disease.

Kumar S, Biancotti JC, Matalon R, de Vellis J.

J Neurosci Res. 2009 Nov 15;87(15):3415-27. doi: 10.1002/jnr.22233.

PMID:
19739253
4.

The dysbindin-containing complex (BLOC-1) in brain: developmental regulation, interaction with SNARE proteins and role in neurite outgrowth.

Ghiani CA, Starcevic M, Rodriguez-Fernandez IA, Nazarian R, Cheli VT, Chan LN, Malvar JS, de Vellis J, Sabatti C, Dell'Angelica EC.

Mol Psychiatry. 2010 Feb;15(2):115, 204-15. doi: 10.1038/mp.2009.58. Epub 2009 Jun 23.

5.

Nur7 is a nonsense mutation in the mouse aspartoacylase gene that causes spongy degeneration of the CNS.

Traka M, Wollmann RL, Cerda SR, Dugas J, Barres BA, Popko B.

J Neurosci. 2008 Nov 5;28(45):11537-49. doi: 10.1523/JNEUROSCI.1490-08.2008.

6.

Events at the transition between cell cycle exit and oligodendrocyte progenitor differentiation: the role of HDAC and YY1.

He Y, Sandoval J, Casaccia-Bonnefil P.

Neuron Glia Biol. 2007 Aug;3(3):221-31. doi: 10.1017/S1740925X08000057.

7.

Myelin lipid abnormalities in the aspartoacylase-deficient tremor rat.

Wang J, Leone P, Wu G, Francis JS, Li H, Jain MR, Serikawa T, Ledeen RW.

Neurochem Res. 2009 Jan;34(1):138-48. doi: 10.1007/s11064-008-9726-5. Epub 2008 May 14.

8.

Nuclear factor I gene expression in the developing forebrain.

Plachez C, Lindwall C, Sunn N, Piper M, Moldrich RX, Campbell CE, Osinski JM, Gronostajski RM, Richards LJ.

J Comp Neurol. 2008 May 20;508(3):385-401. doi: 10.1002/cne.21645.

PMID:
18335562
9.

A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function.

Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, Christopherson KS, Xing Y, Lubischer JL, Krieg PA, Krupenko SA, Thompson WJ, Barres BA.

J Neurosci. 2008 Jan 2;28(1):264-78. doi: 10.1523/JNEUROSCI.4178-07.2008.

10.

Intracellular translocation of glutathione S-transferase pi during oligodendrocyte differentiation in adult rat cerebral cortex in vivo.

Tamura Y, Kataoka Y, Cui Y, Takamori Y, Watanabe Y, Yamada H.

Neuroscience. 2007 Aug 24;148(2):535-40. Epub 2007 Aug 2.

PMID:
17681700
11.

N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.

Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AM.

Prog Neurobiol. 2007 Feb;81(2):89-131. Epub 2007 Jan 5. Review.

12.

Bimodal occurrence of aspartoacylase in myelin and cytosol of brain.

Wang J, Matalon R, Bhatia G, Wu G, Li H, Liu T, Lu ZH, Ledeen RW.

J Neurochem. 2007 Apr;101(2):448-57. Epub 2007 Jan 24.

13.

Mitochondrial transporters as novel targets for intracellular calcium signaling.

Satrústegui J, Pardo B, Del Arco A.

Physiol Rev. 2007 Jan;87(1):29-67. Review.

14.

Epigenetic memory loss in aging oligodendrocytes in the corpus callosum.

Shen S, Liu A, Li J, Wolubah C, Casaccia-Bonnefil P.

Neurobiol Aging. 2008 Mar;29(3):452-63. Epub 2006 Dec 19.

15.

Canavan disease: a white matter disorder.

Kumar S, Mattan NS, de Vellis J.

Ment Retard Dev Disabil Res Rev. 2006;12(2):157-65. Review.

PMID:
16807907
16.

Defective myelin lipid synthesis as a pathogenic mechanism of Canavan disease.

Namboodiri AM, Moffett JR, Arun P, Mathew R, Namboodiri S, Potti A, Hershfield J, Kirmani B, Jacobowitz DM, Madhavarao CN.

Adv Exp Med Biol. 2006;576:145-63; discussion 361-3. Review. No abstract available.

PMID:
16802710
17.

Physiological role of N-acetylaspartate: contribution to myelinogenesis.

Ledeen RW, Wang J, Wu G, Lu ZH, Chakraborty G, Meyenhofer M, Tyring SK, Matalon R.

Adv Exp Med Biol. 2006;576:131-43; discussion 361-3. Review. No abstract available.

PMID:
16802709
18.

Gene expression is differentially regulated by neurotransmitters in embryonic neuronal cortical culture.

Ghiani CA, Lelievre V, Beltran-Parrazal L, Sforza DM, Malvar J, Smith DJ, Charles AC, Ferchmin PA, de Vellis J.

J Neurochem. 2006 Apr;97 Suppl 1:35-43.

19.

Novel role for aspartoacylase in regulation of BDNF and timing of postnatal oligodendrogenesis.

Francis JS, Olariu A, McPhee SW, Leone P.

J Neurosci Res. 2006 Jul;84(1):151-69.

PMID:
16634055
20.

Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease.

Madhavarao CN, Arun P, Moffett JR, Szucs S, Surendran S, Matalon R, Garbern J, Hristova D, Johnson A, Jiang W, Namboodiri MA.

Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5221-6. Epub 2005 Mar 22.

Supplemental Content

Support Center